Women with Higher IQs are More Likely to Smoke Weed

Posted Leave a commentPosted in Women's Interests

Never mind stereotypical stoner humor, cannabis consumers have been shown to be more intelligent than their non-consuming counterparts. And that applies especially to women. According to a new study, women who smoke weed have higher IQs than those who don’t.

Reposted from Jane Street written by  

Researchers from the Journal of Epidemiology and Community Health looked at 800 female cannabis consumers, analyzing data on their intelligence, smoking habits, lifestyle, and schooling level. They found that the majority of female cannabis consumers had higher IQs than the general public, and were 50 percent more intelligent than the average woman — meaning that, the smarter the woman, the more likely she is to smoke pot.

However, though the data proved a correlation between women with higher IQs and cannabis consumption, it didn’t point to why this correlation exists.

Some scientists believe that smarter people might be more open to new experiences, such as new modes of thought and consciousness that cannabis can provide. People who have higher IQs might seek out different or more diverse kinds of mental stimulation. The more cerebral someone is, the more likely they may want to explore the mind in different ways.

And moreover, because cannabis is safe to use and you can’t overdose from it, a smart or cautious drug consumer might also be drawn to the plant.

This isn’t the first time science has shown a connection between intelligence and one’s proclivity toward cannabis. According to a study from the British Medical Journal, people with higher childhood IQs are more likely to use cannabis by the time they turn 30.

Meanwhile, another study from University College London found that middle-schoolers who excelled at school had a higher chance of drinking alcohol and smoking weed when they got to high school, but that they were less likely to smoke cigarettes. However, if a minor were to smoke weed, it could have effects on their performance in school, or on their cognitive development. While a number of children use cannabis for otherwise life-threatening diseases like epilepsy, and have since excelled with the use of products like high-CBD cannabis oil, the average teenager should consider their emotional maturity before altering their minds.

That said, cannabis is known to be a catalyst for new ideas and creativity. No wonder women with high IQs are drawn to cannabis, as it can help maximize and enhance all the activity that’s already happening in their heads.

Women's Cannabis Chamber of CommerceWomen’s Cannabis Chamber of Commerce moving women beyond empowering and inspiring into action and business success.

Smoking Weed

Smoking Weed Improves Brain Functions According to Harvard Study

Posted Leave a commentPosted in Medical Marijuana

Smoking Weed Improves Brain Functions According to Harvard Study. Scientific findings recently published in Frontiers in Pharmacology may have cleared up that mystery of smoking weed and brain function once and for all. Preliminary investigations by medical researchers from McLean Hospital, Harvard Medical School, and Tufts University indicate that pot use improves cognitive performance.

Cognitive performance, no need to tell you, is “our ability to utilize the knowledge acquired by mental processes in our brains.” In other words, perform tasks that require thinking, as in to be so goddamn smart.

The behavioral scientists behind the work summarized in “Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana (Smoking weed) on Executive Function” tracked 24 certified medical-marijuana patients over a three-month dosing period. The patients were repeatedly measured for cognitive proficiency through challenges to the intelligence that included the Stroop Color Word Test and Trail Making Test after smoking weed.

Staci Gruber, PhD, director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program at McLean Hospital—Harvard Medical School’s largest psychiatric affiliate—is the lead “Splendor in the Grass?” researcher. Her initial report is twofold positive. For one thing, weed treatment led to patients breezing through an array of brainteasers with enhanced speed and accuracy.

From a McLean Hospital report:

“After three months of medical marijuana treatment, patients actually performed better, in terms of their ability to perform certain cognitive tasks, specifically those mediated by the frontal cortex,” explained Gruber.

Study participants also reported improvements in their specific clinical conditions, sleep, and overall health as well as a decreased use of conventional medications, particularly opiates.

“We saw a 42 percent reduction in opioid use,” reported Gruber. “This is significant, particularly for those of us in Massachusetts and other areas of the country where the opioid epidemic is ravaging so many. This preliminary finding certainly warrants deeper and broader investigation.”

In less than a week, electorates in five states (one of them being Massachusetts) have the opportunity to vote themselves into the legal-marijuana club. If just one of these states, California for instance, opts for legal adult use, literally millions more Americans will be granted the option to use marijuana without fear of police intervention. Perhaps not everyone who picks up a joint in this newly normalized landscape will become as intelligent as the Kindland smarties.

But you don’t need to be a brilliant visionary to recognize that the preliminary findings from McLean Hospital’s pilot study assessing the favorable impacts of cannabis on adult human brains demand further exploration. Deeper, broader investigations into marijuana’s ability to improve our mental functioning and reduce our susceptibility to opioid dependence should be happening sooner than later.

In that regard, “Splendor in the Grass?” lead Staci Gruber appears to be every bit as invested in the public wellbeing as she is smart in her approach to unraveling and establishing best marijuana practices.

“People are going to use it,” she concludes. “It’s up to us to figure out the very best and safest ways in which they can do that.”

Original Article written by ALLAN MACDONELL, reposted from Kindland

Cannabis classesThe Women’s Cannabis Chamber of Commerce is dedicated to the advancement of women within the Cannabis Industry and canna-centric businesses. WCCC moves beyond empowerment. WCCC offers courses created to provide women with the tools and knowledge to open businesses. WCCC provides mentorship through a community of entrepreneurs dedicated to supporting other women and adhering to a standard of honesty and integrity.  Women’s Cannabis Chamber of Commerce

Marijuana Marketing for Businesses

Groups working to develop standards for cannabis businesses

Posted Leave a commentPosted in Marijuana Policies, Women Owned Cannabis Businesses

Marijuana Marketing for BusinessesCannabis trade groups, state officials and marijuana industry leaders are pursuing the development of standards and best practices covering organic certification, labor practices and energy use in a bid to further legitimize and professionalize the industry.

These efforts could bolster both the marijuana sector’s image among consumers and MJ companies’ bottom lines.

Organic certification, for example, could allow cannabis companies to shore up consumer confidence about the safety of their products and allow businesses to set higher prices for such items – much like organic fruit and vegetable growers.

Standards governing ethical labor and business practices could enable marijuana companies to set themselves apart from rivals.

And standards related to energy use and sustainable practices could help cannabis growers, in particular, become more efficient and thereby more profitable.

While other groups have developed standards for certain parts of the industry in the past – including guidelines on cultivation, manufacturing, labeling, testing and packaging – getting the entire industry to agree to them isn’t easy.

The fragmented cannabis industry lacks national powerhouse companies to help dictate best practices, and a variety of competing views on how standards should be developed makes implementation a steep hill to climb. Without a clear path forward, getting buy-in from industry players is a challenge, to put it mildly.

Organic standards

Recent headlines about pesticide-tainted cannabis in this country and Canada – where consumers have filed lawsuits against federally licensed growers – have underscored the push for organic standards in the marijuana industry.

“It’s critical that a clear, transparent standard is in place for the cannabis industry, because consumers expect that standard to exist,” said Ben Gelt, a board member of the Denver-based Organic Cannabis Association.

Policy makers and industry officials in states across the country, including Washington, Colorado and Maine, are looking at developing organic certification for cannabis.

It’s not an easy task. The federal government regulates standards for organic products, which has introduced a potential stumbling block for those trying to develop cannabis-related standards.

In Colorado, for example, an effort by state lawmakers to develop organic standards last year stalled in part amid concerns the U.S. Department of Agriculture would penalize state regulators for labeling a federally illegal substance as organic.

Gelt, however, said legislation is expected to emerge this year directing the Colorado Department of Agriculture to allow third-party groups to certify cannabis as organic. He’s optimistic such a measure would pass.

“The legislators agree with us that cannabis is here, it exists on the market, and consumers should be able to understand what product is organic and what product is not,” he said.

If organic standards are developed, Gelt expects a cannabis business owner will be in a position to charge more for organically grown marijuana, both at the retail and wholesale level. He likens it to the produce industry.

“If you buy an organic raspberry, it’s usually 15%-25% more expensive than the conventional raspberry,” he said.

Ethical business practices

To gain a leg up on rivals, MJ businesses must distinguish themselves in today’s competitive market, according to Ashley Preece-Sackett, executive director of the Ethical Cannabis Alliance in Portland, Oregon.

Standards governing ethical labor and business practices are one way to do so.

“Organizations and farms are looking for ways to let the consumer know that they care,” Preece-Sackett said. This would be a way for a cannabis business to show that its product is different and “better,” she added.

The ECA is looking to other industries for guidance while it develops its own standards.

“We’re not reinventing any wheel. We’re actually looking at fair trade standards and we’re ‘cannabinizing’ them so that we can have similar standards within our industry,” Preece-Sackett said.

ECA’s mission is to either create the standards for labor and business ethics on its own, or to link with other organizations for a unified voice. Those groups include the Organic Cannabis Association and the Resource Innovation Institute, a nonprofit that promotes energy and water conservation among MJ cultivators.

Linking the three organizations for such an effort could create a national approach, she said.

Preece-Sackett expects the ECA could have a “cannabinized” set of standards to market within the next three months.

“Once consumers catch up to that idea with cannabis, they’re going to be asking for those ethically grown products,” she added.


Read entire article by Bart Schaneman at Marijuana Business Daily


DEA Approves Synthetic Cannabis Medication by Anti-Cannabis Pharmaceutical Giant

Posted Leave a commentPosted in Medical Marijuana

CannabisThe Drug Enforcement Administration has approved Syndros, a cannabis-based medication developed by pharmaceutical company Insys Therapeutics, for Schedule II status under the Controlled Substances Act, according to a Chicago Tribune report.

Syndros is an oral remedy that uses THC to treat nausea and vomiting, two of the most common symptoms caused by chemotherapy. The drug was pre-approved by the FDA last summer as a treatment for nausea, vomiting, and weightloss in cancer and AIDS patients.

If that name Insys sounds familiar, it’s probably because this is the pharma group that donated $500,000 last September to help defeat Arizona’s cannabis legalization campaign; and now the company has received DEA approval for its own cannabis-based drug. During the campaign, the company said it opposed the legalization measure because, “it [would fail] to protect the safety of Arizona’s citizens, and particularly its children.” Now, non-medical cannabis users in Arizona must still face felony charges for possessing even small amounts of the plant.

However, if safety were truly Insys’ biggest concern, they might rethink their aggressive marketing strategies for Subsys — a medication containing fentanyl, a dangerously powerful and addictive opiate that can be 50-100 times more powerful than Morphine.

“It appears they are trying to kill a non-pharmaceutical market for marijuana in order to line their own pockets,” a spokesperson for Arizona’s legalization campaign said last year.

It’s clear that in a world where anyone and everyone would be allowed to cultivate their own medicine, giant pharma companies such as Insys would inevitably lose revenue. However, according to Kevin Gallagher of Craft Concentrates and the Cannabis Business Alliance, Big Pharma interests may ultimately be surprised by the zeal and persistence of cannabis patients and advocates.

“This is a completely unique substance that is so readily available, and it’s so easy to take advantage of its healing nature, … it’ll be very interesting to see how that plays out,” Gallagher said in an interview with Westword.

“These pharmaceutical companies still think they’re going to win the battle in creating essentially fake cannabis and having to even compete with the real cannabis industry, but they’re not looking at the effects of certain terpenes or certain cannabinoids,” Gallagher said.

More and more Americans succumb to prescription opiate overdoses each year, while there remain zero recorded deaths contributed to the over-consumption of cannabis.

Original article from Ganjapreneur  March 27, 2017 written by Graham Abbott